NATCO files ANDA for Trifluridine/ Tipiracil Hydrochloride Tablets

NATCO believes that it is one of the first ANDA filers for the product and could be eligible for 180 days exclusivity under certain circumstances.

from India Infoline News Service https://ift.tt/37C0KTn